Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

positive   crawled date : 2021 - 04 - 20    save search

Evelo Biosciences Presents Further Positive Data from Phase 1b Clinical Trial of EDP1815 in Atopic Dermatitis
Published: 2021-04-20 (Crawled : 21:00) - evelobio.com
EVLO | $0.3165 -87.39% 710K twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 10.96% C: 9.47%

phase 1 positive dermatitis trial atopic dermatitis phase 1b phase 2b bioscience
Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
SRNE | $0.024 -14.29% -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 1.85% C: -1.72%

covid treatment positive results phase 1 positive results phase 1b phase 2b
Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas
Published: 2021-04-20 (Crawled : 12:00) - biospace.com/
AUTL | $4.8 -0.83% -0.83% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 1.88% C: -2.26%

treatment positive t-cell
Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis (ALS)
Published: 2021-04-20 (Crawled : 12:00) - biospace.com/
SEEL | $0.338 1.81% -3.11% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.6% C: 2.0%

positive drug sclerosis ema als designation
Syndax Announces Positive Interim Data Demonstrating Robust Clinical Activity in Phase 1 Portion of the AUGMENT-101 Trial of SNDX-5613 in Patients with Genetically-Defined Acute Leukemias
Published: 2021-04-20 (Crawled : 12:00) - biospace.com/
SNDX | $20.44 -1.45% -1.47% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -10.99% H: 2.38% C: -22.2%

genetic phase 1 positive leukemia trial phase 2 phase 3
Jacobs/Morrison Utility Services Joint Venture Awarded Position on National Grid's Six-year Transmission Substation Delivery Framework
Published: 2021-04-20 (Crawled : 08:00) - prnewswire.com
J | News | $143.5 0.37% 0.0% 310K twitter stocktwits trandingview |
Industrial Services
| | O: 0.0% H: 0.34% C: -0.4%

liver positive
Gainers vs Losers
61% 39%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $1.45 5.84% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.421 97.65% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.509 23.81% 45.26% 90K twitter stocktwits trandingview |

GDHG | $0.263 21.76% 40.66% 3.1M twitter stocktwits trandingview |

XPON | News | $3.15 63.21% 37.74% 16M twitter stocktwits trandingview |

TIRX | $0.8 65.02% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.